Mimedx (MDXG) Capital Expenditures (2011 - 2026)

Mimedx has disclosed Capital Expenditures across 16 years of filings, most recently posting $570000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $570000.0, up 51.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 33.84% YoY), and the FY2025 annual result was $1.0 million, down 38.62% from the prior year.
• Capital Expenditures came in at $570000.0 for Q1 2026 at Mimedx, up from $285000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q4 2023 to a low of -$932000.0 in Q3 2023.
• The 5-year median for Capital Expenditures is $299000.0 (2023), against an average of $399235.3.
• Peak annual rise in Capital Expenditures reached 436.44% in 2023, while the deepest fall reached 367.05% in 2023.
• Mimedx's Capital Expenditures stood at $667000.0 in 2022, then soared by 197.9% to $2.0 million in 2023, then slumped by 86.76% to $263000.0 in 2024, then rose by 8.37% to $285000.0 in 2025, then soared by 100.0% to $570000.0 in 2026.
• The last three Capital Expenditures figures came in at $570000.0 (Q1 2026), $285000.0 (Q4 2025), and $192000.0 (Q3 2025), per Business Quant data.